Reduced parahippocampal and lateral temporal GABAA-[11C]flumazenil binding in major depression: preliminary results
Open accessThe DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Abstract
Purpose Major depressive disorder (MDD) has been related to both a dysfunctional gamma-amino butyric acid (GABA) system and to hyperactivity of the hypothalamic-pituitary-adrenal axis (HPA). Although GABA has been suggested to inhibit HPA axis activity, their relationship has never been studied at the level of the central GABA(A)-benzodiazepine receptor in depressed patients or in relation to antidepressant treatment. Methods Eleven depressed outpatients were compared, before and after treatment with citalopram, with nine age-matched healthy controls. The subjects were scanned using the positron emission tomography (PET) tracer [(11)C]flumazenil ([(11)C]FMZ). Parametric voxel-by-voxel Logan plots were compared with methods based on regions of interest (ROI), to provide volume of distribution (V(T)) and binding potential (BP(ND)) values. Plasma GABA levels were determined and a dexamethasone-corticotropin releasing hormone (DEX-CRH) test was performed. Results In MDD, parametric voxel-by-voxel Logan plots showed bilateral reduced [(11)C]FMZ binding in the parahippocampal gyrus and right lateral superior temporal gyrus (p uncorrected Conclusion The bilateral reduction in limbic parahippocampal and right temporal [(11)C]FMZ binding found in MDD indicates decreased GABA(A)-benzodiazepine receptor complex affinity and/or number. The inverse relationship between GABA(A) binding in the temporal lobe and HPA axis activity, suggests that HPA axis hyperactivity is partly due to reduced…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Likewise, reductions in both GABAA and GABAB receptor-mediated inhibition in MDD have been demonstrated across genomic [64], postmortem [65], and neuroimaging studies [28,48].”
From Pharmacotherapies Targeting GABA-Glutamate Neurotransmission for Treatment-Resistant Depression (2023) · cites this paper as [48]
Citations
Cites
An inventory for measuring depression
BECK, A. T. (1961) · Archives of General Psychiatry · doi:10.1001/archpsyc.1961.01710120031004 · Cited by 38,032 · cited 1×
“Patients completed the Beck depression inventory (BDI) [30], the Hamilton anxiety rating scale (HAM-A) [31] and the Montgomery Åsberg depression rating scale (MADRS) [32].”
MethodA new depression scale designed to be sensitive to change
Montgomery, S. A., & Åsberg, M. (1979) · British Journal of Psychiatry · doi:10.1192/bjp.134.4.382 · Cited by 13,962 · cited 1×
“Patients completed the Beck depression inventory (BDI) [30], the Hamilton anxiety rating scale (HAM-A) [31] and the Montgomery Åsberg depression rating scale (MADRS) [32].”
MethodThe assessment of anxiety states by rating
HAMILTON, M. (1959) · British Journal of Medical Psychology · doi:10.1111/j.2044-8341.1959.tb00467.x · Cited by 11,455 · cited 1×
“Patients completed the Beck depression inventory (BDI) [30], the Hamilton anxiety rating scale (HAM-A) [31] and the Montgomery Åsberg depression rating scale (MADRS) [32].”
Method(1976) · Medical Entomology and Zoology · Cited by 8,899
Multimodality image registration by maximization of mutual information
Maes, F., Collignon, A., Vandermeulen, D., Marchal, G., & Suetens, P. (1997) · IEEE Transactions on Medical Imaging · doi:10.1109/42.563664 · Cited by 4,547 · cited 1×
“MRI scans were coregistered with summed [C]FMZ images (10–60 min after injection) [38, 39].”
MethodStructured Clinical Interview for DSM-IV Axis I Disorders
Spitzer, R. L., First, M. B., & Gibbon, M. (1997) · Medical Entomology and Zoology · Cited by 4,094
Drevets, W. C., Price, J. L., & Furey, M. L. (2008) · Brain Structure and Function · doi:10.1007/s00429-008-0189-x · Cited by 2,241 · cited 1×
“pathophysiology of depression and anxiety, that is the right temporal gyrus and the ventrolateral prefrontal cortex, indicating that high depression scores are related to low [ 11 C]FMZ binding [ 57 ].”
BackgroundSimplified Reference Tissue Model for PET Receptor Studies
Lammertsma, A. A., & Hume, S. P. (1996) · NeuroImage · doi:10.1006/nimg.1996.0066 · Cited by 2,021 · cited 1×
“ROI time–activity curves, VT, obtained using a single tissue (1T) compartment model with metabolite-corrected plasma input function and an additional parameter for blood volume, was compared with nondisplaceable binding potential (BPND) values obtained using the simplified reference tissue model (SRTM) [ 44 ] with the…”
MethodSelf-citationLogan, J., Fowler, J. S., Volkow, N. D., Wolf, A. P., Dewey, S. L., Schlyer, D. J., MacGregor, R. R., Hitzemann, R., Bendriem, B., Gatley, S. J., et al. (1990) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1990.127 · Cited by 1,479
(2025) · Springer Reference Medizin · doi:10.1007/978-3-662-65186-5_300379 · Cited by 1,445
Research works printed but not linked: 1
- Spielberger CD, Gorsuch RL, Lushene RE. STAI manual. Palo Alto, California: Consulting Psychologists Press; 1970.
Cited by
The GABA system in anxiety and depression and its therapeutic potential
Möhler, H. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.08.040 · Cited by 590
“2) Cortical GABAA receptors and cortical GABA neurons are reduced in major depression (Klumpers et al., 2010; Rajkowska et al., 1999, 2007)”
BackgroundMethodStructural and functional neuroimaging studies of the suicidal brain
Desmyter, S., van Heeringen, C., & Audenaert, K. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.12.026 · Cited by 215
“The inverse relationship between GABAA binding in the temporal lobe and HPA axis activity, suggests that HPA axis hyperactivity is partly due to reduced GABAergic inhibition (Klumpers et al., 2010).”
BackgroundFuchs, T., Jefferson, S. J., Hooper, A., Yee, P.-H., Maguire, J., & Luscher, B. (2017) · Molecular Psychiatry · doi:10.1038/mp.2016.188 · Cited by 204
“Conversely, MDD is also associated with reduced concentrations of GABA 5–10 , reduced expression of GABA type A receptors (GABA A Rs) 11 , reduced expression of glutamic acid decarboxylase (GAD) 12, 13 and impaired function of certain subtypes of GABAergic interneurons 14–16 .”
Ghosal, S., Hare, B. D., & Duman, R. S. (2017) · Current Opinion in Behavioral Sciences · doi:10.1016/j.cobeha.2016.09.012 · Cited by 199
Convergent Mechanisms Underlying Rapid Antidepressant Action
Zanos, P., Thompson, S. M., Duman, R. S., Zarate, C. A., & Gould, T. D. (2018) · CNS Drugs · doi:10.1007/s40263-018-0492-x · Cited by 171
Plante, D. T., Jensen, J. E., Schoerning, L., & Winkelman, J. W. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.4 · Cited by 159
GABAergic Control of Depression-Related Brain States
Luscher, B., & Fuchs, T. (2015) · Advances in Pharmacology · doi:10.1016/bs.apha.2014.11.003 · Cited by 149
“…suggesting reduced GABAergic transmission in depressed patients is based on positron emission tomography (PET) imaging of [11C]-flumazenil binding (Klumpers et al., 2010), These studies revealed reduced expression of GABAARs in the limbic parahippocampal temporal gyrus and right lateral superior…”
BackgroundPehrson, A., & Sanchez, C. (2015) · Drug Design, Development and Therapy · doi:10.2147/dddt.s62912 · Cited by 145
“A recent study by Klumpers et al 57 found significant reductions in benzodiazepine-site binding in the parahippocampal gyrus and right lateral superior temporal gyrus of a small sample of MDD patients.”
Cutler, A. J., Mattingly, G. W., & Maletic, V. (2023) · Translational Psychiatry · doi:10.1038/s41398-023-02514-2 · Cited by 194
“Positron emission tomography imaging showed reduced GABAA receptor binding of [ (11)C]-flumazenil in the limbic parahippocampal temporal gyrus and right lateral superior temporal gyrus of individuals with MDD versus healthy controls, suggesting a decreased number of GABAA receptors and/or reduced affinity to benzodiaz…”
BackgroundPluripotent stem cells in neuropsychiatric disorders
Soliman, M. A., Aboharb, F., Zeltner, N., & Studer, L. (2017) · Molecular Psychiatry · doi:10.1038/mp.2017.40 · Cited by 143
Ren, Z., Pribiag, H., Jefferson, S. J., Shorey, M., Fuchs, T., Stellwagen, D., & Luscher, B. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.02.009 · Cited by 114
Lüscher, B., & Möhler, H. (2019) · F1000Research · doi:10.12688/f1000research.18758.1 · Cited by 105
Thompson, S. M. (2023) · Neuropsychopharmacology · doi:10.1038/s41386-023-01728-8 · Cited by 103
Striatal structure and function in mood disorders: a comprehensive review
Marchand, W. R., & Yurgelun‐Todd, D. (2010) · Bipolar Disorders · doi:10.1111/j.1399-5618.2010.00874.x · Cited by 91
Helmstaedter, C., Aldenkamp, A. P., Baker, G. A., Mazarati, A. M., Ryvlin, P., & Sankar, R. (2013) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2013.11.010 · Cited by 78
“This is in contrast with studies performed in patients with major depressive disorders and no epilepsy, which demonstrate converging evidence of altered cortical excitability [71] and inhibition [72], reduced GABA concentration [73] and GABAA-benzodiazepine receptor density [74], altered 5-HT1A receptors [75], hippoca…”
ResultKim, Y. K., Yang, E. J., Cho, K., Lim, J. Y., & Paik, N. (2014) · Neurorehabilitation and neural repair · doi:10.1177/1545968313520411 · Cited by 90
“The functional alteration of GABAergic neurons has been studied in several neuropsychiatric disorders using FMZ PET.(14,15) We believe that the FMZ binding in our study reflected the functional alteration and neuronal density of GABA.”
MethodEpilepsy, cognition, and neuropsychiatry (Epilepsy, Brain, and Mind, part 2)
Korczyn, A. D., Schachter, S. C., Brodie, M. J., Dalal, S. S., Engel, J., Guekht, A., Hecimovic, H., Jerbi, K., Kanner, A. M., Johannessen Landmark, C., et al. (2013) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2013.03.012 · Cited by 57
“depression, primarily affecting the parahippocampal region and the lateral temporal cortex [156].”
BackgroundUpregulation of cortical GABAA receptor concentration in fibromyalgia
Pomares, F. B., Roy, S., Funck, T., Feier, N. A., Thiel, A., Fitzcharles, M., & Schweinhardt, P. (2019) · Pain · doi:10.1097/j.pain.0000000000001707 · Cited by 64
“The notion of decreased GABA levels has been supported in the insula in diabetic neuropathy36 and has been associated with higher pain levels in the ACC in knee osteoarthritis.40 This is also supported by another PET study showing that flumazenil BPND correlated inversely with plasma levels of GABA.25 GABA levels coul…”
BackgroundThe role of allopregnanolone in depressive-like behaviors: Focus on neurotrophic proteins
Almeida, F. B., Nin, M. S., & Barros, H. M. T. (2020) · Neurobiology of Stress · doi:10.1016/j.ynstr.2020.100218 · Cited by 53
Lussier, A. L., Romay-Tallón, R., Caruncho, H. J., & Kalynchuk, L. E. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.11.037 · Cited by 58
Rapid-Acting Antidepressants: Mechanistic Insights and Future Directions
Gerhard, D. M., & Duman, R. S. (2018) · Current Behavioral Neuroscience Reports · doi:10.1007/s40473-018-0139-8 · Cited by 52
The Role of GABA in Primary Insomnia
Plante, D. T., Jensen, J. E., & Winkelman, J. W. (2012) · SLEEP · doi:10.5665/sleep.1854 · Cited by 51
Vithlani, M., Hines, R. M., Zhong, P., Terunuma, M., Hines, D. J., Revilla-Sanchez, R., Jurd, R., Haydon, P., Rios, M., Brandon, N., et al. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.1845-13.2013 · Cited by 51
“Clinical studies from depressed patients show reductions in the level of GABAAR expression in the prefrontal cortex (PFC; Feighner et al., 1983; Petty et al., 1995; Earnheart et al., 2007; Kalueff and Nutt, 2007; Maguire and Mody, 2008; Klumpers et al., 2010).”
BackgroundIdentification of a novel, fast-acting GABAergic antidepressant
McMurray, K. M. J., Ramaker, M. J., Barkley-Levenson, A. M., Sidhu, P. S., Elkin, P. K., Reddy, M. K., Guthrie, M. L., Cook, J. M., Rawal, V. H., Arnold, L. A., et al. (2018) · Molecular Psychiatry · doi:10.1038/mp.2017.14 · Cited by 50
Pharmacotherapies Targeting GABA-Glutamate Neurotransmission for Treatment-Resistant Depression
Vecera, C. M., C. Courtes, A., Jones, G., Soares, J. C., & Machado-Vieira, R. (2023) · Pharmaceuticals · doi:10.3390/ph16111572 · Cited by 48
“These areas are highly implicated in the adverse cognitive and affective features of depression, especially rumination and anhedonia [3,48].”
BackgroundThe role of the excitation:inhibition functional balance in the mPFC in the onset of antidepressants
Yin, Y., Wang, Y., Liu, W., Yao, J.-Q., Yuan, J., Li, Z.-H., Ran, Y., Zhang, L., & Li, Y. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108573 · Cited by 54
Ren, Z., Sahir, N., Murakami, S., Luellen, B. A., Earnheart, J. C., Lal, R., Kim, J. Y., Song, H., & Luscher, B. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.07.019 · Cited by 47
“, 2012), altered expression of GABAA receptors (GABAARs) (Merali et al., 2004; Choudary et al., 2005; Sequeira et al., 2007; Klempan et al., 2009; Klumpers et al., 2010), compromised function or loss of GABAergic interneurons (Rajkowska et al.”
BackgroundDecreased carbon-11-flumazenil binding in early Alzheimer’s disease
Pascual, B., Prieto, E., Arbizu, J., Marti-Climent, J. M., Peñuelas, I., Quincoces, G., Zarauza, R., Pappatà, S., & Masdeu, J. C. (2012) · Brain · doi:10.1093/brain/aws210 · Cited by 45
“…potential confounders were vascular disease and depression, both of which have been reported to lower [ 11 C]- flumazenil binding (Heiss et al. , 2004; Klumpers et al. , 2010 (Pascual et al. , 2010), where Alzheimer’s disease was compared with microvascular disease, the type of vascular disease…”
BackgroundWisłowska-Stanek, A., Lehner, M., Skórzewska, A., Krząścik, P., Maciejak, P., Szyndler, J., Ziemba, A. W., & Płaźnik, A. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.07.042 · Cited by 47
Freeman, L. A., García-Lorenzo, D., Bottin, L., Leroy, C., Louapre, C., Bodini, B., Papeix, C., Assouad, R., Granger, B., Tourbah, A., et al. (2015) · Annals of Neurology · doi:10.1002/ana.24468 · Cited by 48
Sanacora, G. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.01.003 · Cited by 45
Positron emission tomography imaging of the γ-aminobutyric acid system
Andersson, J. D., Matuskey, D., & Finnema, S. J. (2018) · Neuroscience Letters · doi:10.1016/j.neulet.2018.08.010 · Cited by 39
Long-lasting antidepressant-like activity of the GPR39 zinc receptor agonist TC-G 1008
Starowicz, G., Jarosz, M., Frąckiewicz, E., Grzechnik, N., Ostachowicz, B., Nowak, G., & Młyniec, K. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.11.003 · Cited by 38
Shaw, A. D., Brealy, J., Richardson, H., Muthukumaraswamy, S. D., Edden, R. A. E., Evans, J., Puts, N. A. J., Singh, K. D., & Keedwell, P. A. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.09.032 · Cited by 39
The utility of PET imaging in depression
Singh, S. B., Tiwari, A., Katta, M. R., Kafle, R., Ayubcha, C., Patel, K. H., Bhattarai, Y., Werner, T. J., Alavi, A. A., & Revheim, M.-E. R. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1322118 · Cited by 37
Michopoulos, V., Embree, M., Reding, K. M., Sanchez, M. M., Toufexis, D. J., Votaw, J. R., Voll, R. J., Goodman, M. M., Rivier, J., Wilson, M. E., et al. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.07.002 · Cited by 30
“Recent studies in humans have shown GABAAR binding is decreased in brain regions involved in emotional regulation and the control of the LHPA axis in individuals with posttraumatic stress disorder and depression (Cameron et al, 2007; Geuze et al, 2008; Klumpers et al, 2010).”
BackgroundInfluentialCuypers, K., Hehl, M., van Aalst, J., Chalavi, S., Mikkelsen, M. E., Laere, K. V., Dupont, P. J., Mantini, D., & Swinnen, S. P. (2020) · NeuroImage · doi:10.1016/j.neuroimage.2020.117536 · Cited by 41
Ran, Q., Chen, J., Li, C., Li, W., Yue, F., Shu, T., Mi, J., Wang, G., Zhang, L., Gao, D., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.17921 · Cited by 31
“This observation suggests that the hyperarousal state in insomnia is correlated with decreased GABA and that an imbalance between inhibitory and excitatory function appears if there is an abnormality of the excretion of any inhibitory or excitatory neurotransmission [20, 22, 23, 57].”
BackgroundPositron emission tomography in psychiatric disorders
Newberg, A. B., Moss, A., Monti, D., & Alavi, A. A. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2011.06162.x · Cited by 31
Persson, J., Wall, A. E., Weis, J., Gingnell, M., Antoni, G., Lubberink, M., & Bodén, R. (2021) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2021.111327 · Cited by 31
Molecular Neurobiology of Depression: PET Findings on the Elusive Correlation with Symptom Severity
Smith, D. F., & Jakobsen, S. (2013) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2013.00008 · Cited by 25
Disruptions to the cerebellar GABAergic system in juvenile guinea pigs following preterm birth
Shaw, J. C., Palliser, H. K., Dyson, R. M., Berry, M. J., & Hirst, J. J. (2017) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2017.10.002 · Cited by 27
“…schizophrenia (Akbarian and Huang, 2006) and mood disorders (Edden et al., 2012a; Sterley et al., 2013; Nutt and Malizia, 2004; Hasler et al., 2008; Klumpers et al., 2010; Sanacora et al., 1999; Merali et al., 2004; Sanacora et al., 2004; Fatemi et al., 2005), children with ADHD (Edden et al.,…”
BackgroundResultInfluentialMolecular imaging in patients with mood disorders: a review of PET findings
Chen, Q., Liu, W., Li, H., Zhang, H., & Tian, M. (2011) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-011-1779-z · Cited by 27
“Additionally, in a study using [(11)C]flumazenil and PET in patients with MDD treated with citalopram, GABAAR binding was reduced in the right lateral temporal gyrus and DLPFC after 6 weeks of treatment [71].”
ResultInfluentialDevelopment of psychopathology in deployed armed forces in relation to plasma GABA levels
Schür, R. R., Boks, M. P., Geuze, E., Prinsen, H. C. M. T., Verhoeven‐Duif, N. M., Joëls, M., Kahn, R. S., Vermetten, E. H. G. J. M., & Vinkers, C. H. (2016) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2016.08.014 · Cited by 25
Wu, X., Balesar, R. A., Lü, J., Farajnia, S., Zhu, Q., Huang, M., Bao, A., & Swaab, D. F. (2017) · Brain Structure and Function · doi:10.1007/s00429-017-1442-y · Cited by 26
Liu, C., Zhang, L., Wu, J., Sui, X., Xu, Y., Huang, L., Han, Y., Zhu, H., Li, Y., Sun, X., et al. (2017) · Experimental Brain Research · doi:10.1007/s00221-017-5056-7 · Cited by 25
Brenna, C. T. A., Goldstein, B. I., Zarate, C. A., & Orser, B. A. (2024) · Anesthesiology · doi:10.1097/aln.0000000000005037 · Cited by 24
Zong, S., Hoffmann, C., Mané-Damas, M., Molenaar, P. C., Losen, M. H., & Martínez‐Martínez, P. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00752 · Cited by 24
Shaw, J. C., Crombie, G. K., Zakár, T., Palliser, H. K., & Hirst, J. J. (2019) · Journal of Neuroendocrinology · doi:10.1111/jne.12814 · Cited by 24
Do certain signal transduction mechanisms explain the comorbidity of epilepsy and mood disorders?
Rocha, L., Alonso‐Vanegas, M., Orozco-Suárez, S. A., Alcantara‐Gonzalez, D., Cruzblanca, H., & Castro, E. (2014) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2014.01.001 · Cited by 23
“areas of subjects with anxiety or depression, a situation that has been inversely correlatedwith total plasmaGABA levels [62,63].”
BackgroundNagasawa, M., Otsuka, T., Togo, Y., Yamanaga, M., Yoshida, J., Uotsu, N., Teramoto, S., Yasuo, S., & Furuse, M. (2017) · Amino Acids · doi:10.1007/s00726-017-2448-8 · Cited by 20
“In the present study, the prefrontal cortex and hippocampus were focused because these brain regions are closely linked the pathogenesis for the mechanism for the major depression (Warner-Schmidt and Duman 2006; Rajkowska et al. 2007; Klumpers et al. 2010).”
Molecular Imaging for Depressive Disorders
Lee, T. S., Quek, S., & Krishnan, K. R. R. (2014) · American Journal of Neuroradiology · doi:10.3174/ajnr.a3965 · Cited by 21
Nikoui, V., Ostadhadi, S., Azhand, P., Zolfaghari, S., Amiri, S., Foroohandeh, M., Motevalian, M., Sharifi, A. M., & Bakhtiarian, A. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2016.09.017 · Cited by 18
Ostadhadi, S., Akbarian, R., Norouzi‐Javidan, A., Nikoui, V., Zolfaghari, S., Chamanara, M., & Dehpour, A. R. (2017) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2016-0292 · Cited by 17
PET Imaging in Psychiatric Disorders
Ferrando, R., Hernandes, D., Ghini, B. G., & Coutinho, A. M. (2025) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2025.06.004 · Cited by 21
Feklicheva, I. V., Boks, M. P., de Kloet, E. R., Chipeeva, N., Павловна, М. Е., Pashkov, A. A., Korobova, S. Y., Komelkova, M. V., Kuznetsova, Y., Platkovski, P., et al. (2021) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2021.11.032 · Cited by 21
“, 1986), correlate with GABA receptor binding in the anterior and posterior cingulate cortex, temporal cortex, and insula (Klumpers et al., 2010).”
BackgroundRelationship Between Obesity and Depression Considering the Inflammatory Theory
Oracz, A. J., Zwierz, M., Naumowicz, M., Suprunowicz, M., & Waszkiewicz, N. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26114966 · Cited by 24
“A positron emission tomography (PET) study using the [¹¹C]-flumazenil tracer revealed reduced binding of the GABA-A receptor in patients with depressive disorders in specific brain regions, including the hippocampal gyrus and the right superior temporal cortex [253].”
James, G. M., Gryglewski, G., Vanicek, T., Berroterán-Infante, N., Philippe, C., Kautzky, A., Nics, L., Vraka, C., Godbersen, G. M., Unterholzner, J., et al. (2018) · Cerebral Cortex · doi:10.1093/cercor/bhy249 · Cited by 14
Convergent molecular and structural neuroimaging signatures of first-episode depression
Chen, Y., Chen, Y., Zheng, R., Jiang, Y. B., Zhou, B., Xue, K., Li, S., Pang, J., Li, H., Zhang, Y., et al. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.09.132 · Cited by 16
James, D. M., Lam, V. T., Jo, B., & Fung, L. K. (2022) · Autism Research · doi:10.1002/aur.2703 · Cited by 16
Molecular Targets of Cannabinoids Associated with Depression
Paudel, P., Ross, S. A., & Li, X. (2021) · Current Medicinal Chemistry · doi:10.2174/0929867328666210623144658 · Cited by 14
Integrative neuroimaging in mood disorders
Keedwell, P. A., & Linden, D. E. J. (2012) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e32835a0b63 · Cited by 13
“Abnormal subcortical GABA function has been demonstrated in animal models of depression [27], and a small study of [(11)C]flumazenil binding in MDD [28].”
BackgroundParametric [11C]flumazenil images
Klumpers, U. M. H., Boellaard, R., Veltman, D. J., Kloet, R. W., Hoogendijk, W. J. G., & Lammertsma, A. A. (2012) · Nuclear Medicine Communications · doi:10.1097/mnm.0b013e3283505f7b · Cited by 12
Self-citationA Clinician’s Guide to Functional Hypothalamic Amenorrhea
Ruiz-Zambrana, Á., & Berga, S. L. (2020) · Clinical Obstetrics & Gynecology · doi:10.1097/grf.0000000000000573 · Cited by 12
Szilágyi, T., Száva, I., Metz, J., Mihály, I., & Orbán-Kis, K. (2014) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2014.08.004 · Cited by 13
Castanheira, S., Gomes, C. V., Bicker, J., & Fortuna, A. C. (2025) · Drug Discovery Today · doi:10.1016/j.drudis.2025.104371 · Cited by 11
Personalized psychiatry with human iPSCs and neuronal reprogramming
Bardy, C., Greenberg, Z., Perry, S. W., & Licinio, J. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813176-3.00012-2 · Cited by 10
Human Biodistribution and Dosimetry of the PET Radioligand [11C]Flumazenil (FMZ)
Laymon, C. M., Narendran, R., Mason, N. S., Carney, J., Lopresti, B. J., Mathis, C. A., Mountz, J. M., Sashin, D., & Frankle, W. G. (2011) · Molecular Imaging and Biology · doi:10.1007/s11307-011-0478-2 · Cited by 8
Biological Models of Unipolar Depression
Cleare, A. J. (2004) · Wiley eBooks · doi:10.1002/9780470696385.ch2 · Cited by 10
Mechanistic Study on the Possible Role of Embelin in Treating Neurodegenerative Disorders
Anika, Arora, R., Virendra, S. A., & Chawla, P. A. (2023) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527322666230119100053 · Cited by 9
Role of PET in the Investigation of Neuropsychiatric Disorders
Newberg, A. B., & Alavi, A. A. (2010) · PET Clinics · doi:10.1016/j.cpet.2010.03.003 · Cited by 8
Steinholtz, L., Bodén, R., Wall, A. E., Lubberink, M., Fällmar, D., & Persson, J. (2025) · Translational Psychiatry · doi:10.1038/s41398-025-03371-x · Cited by 8
“GABA A -receptor availability GABA A -receptor availability in the context of rTMS for depression has not been examined earlier; however, there have been a few studies investigating GABA A -receptor availability in depression disorders [18 – 20].”
GABAergic transmission and modulation of anxiety: A review on molecular aspects
Gomes, F. I. F., Aragão, M. G. B., Bezerra, M. M., & Chaves, H. V. (2019) · Brazilian Journal of Biological Sciences · doi:10.21472/bjbs.061202 · Cited by 8
“…based on the available literature showing that patients can present a deficit in cortical GABA levels (Sanacora et al., 1999; Hasler et al., 2007), a deficit in cortical GABAA receptors (Klumpers et al., 2010) or a deficit in the number of cortical GABA neurons (Rajkowska et al., 1999; 2007).”
BackgroundPositron emission tomography in neurological and psychiatric disorders
Newberg, A. B., Monti, D., Moss, A., & Alavi, A. A. (2012) · International Journal of Imaging Systems and Technology · doi:10.1002/ima.22004 · Cited by 4
Hernández-Contreras, K. A., Martínez-Díaz, J. A., Hernández‐Aguilar, M. E., Herrera‐Covarrubias, D., Rojas-Durán, F., & Aranda-Abreu, G. E. (2021) · Revista Colombiana de Psiquiatría · doi:10.1016/j.rcp.2021.10.007 · Cited by 4
Neuroprotective roles of neurotrophic growth factors in mood disorders
Jiang, C. S., & Salton, S. R. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814037-6.00010-0 · Cited by 4
Rapid Anti-Depressant Relief by Ketamine: Exploring A Complex Mechanism of Action
Blum, K., Pappas, T. C., Clifton, B., Baron, D. A., Madigan, M. A., Lott, L., Moran, M., Clifton, C., Worrich, S., Clarke, E., et al. (2019) · Current Psychopharmacologye · doi:10.2174/2211556008666190827150018 · Cited by 4
Trajectories of late-life depression: insights from molecular imaging
Holmes, S. E., & Smith, G. S. (2026) · Neuropsychopharmacology · doi:10.1038/s41386-026-02340-2 · Cited by 2
Steinholtz, L., Thörnblom, E., Bodén, R., Wall, A. E., Axelson, H. W., Lubberink, M., Fällmar, D., & Persson, J. (2023) · Neuropsychobiology · doi:10.1159/000535512 · Cited by 3
“This is similar to a SPECT study that could not fi nd any difference in benzodiazepine-binding in depressed and healthy controls, but opposed to a PET study that found reduced temporal GABA A receptor binding in depressed patients [15, 16].”
ResultBiological Models of Unipolar Depression
Cleare, A. J., & Rane, L. J. (2013) · Wiley eBooks · doi:10.1002/9781118316153.ch2 · Cited by 5
Bumetanide and use in depressive states
Tessier, M., Rezzag, A., Pellegrino, C., & Rivera, C. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-817933-8.00053-0 · Cited by 1
Could stem cells have a role in treating mental illnesses?
Arbuck, D. M. (2021) · Current Psychiatry · doi:10.12788/cp.0192 · Cited by 1
Tiger, M., & Lundberg, J. (2022) · Neuromethods · doi:10.1007/978-1-0716-2083-0_11 · Cited by 1
Stormezand, G. N., Borra, R., Klein, H. C., van Laar, P. J., Boellaard, R., & Dierckx, R. A. J. O. (2016) · Springer eBooks · doi:10.1007/978-3-319-31614-7_9 · Cited by 1
Self-citationExamining reelin expression and neural plasticity in animal models of depression
Lussier, A. L. (2012) · University Library - University of Saskatchewan (University of Saskatchewan)
PET IMAGING OF THE PHARMACOKINETICS OF SMALL MOLECULAR‐WEIGHT DRUGS
Moerlein, S. M., & Tu, Z. (2013) · Wiley eBooks · doi:10.1002/9781118356845.ch7
Autoantibodies in disorders of the brain: expanding the spectrum
Зонг (2019) · Research Publications (Maastricht University) · doi:10.26481/dis.20191106sz
Current Awareness in Labelled Compounds and Radiopharmaceuticals
(2010) · Journal of Labelled Compounds and Radiopharmaceuticals · doi:10.1002/jlcr.1682
Effect of Somatostatin-Expressing Interneuron Deficits in Depression
郭, 沉. (2019) · Advances in Psychology · doi:10.12677/ap.2019.910214
Heinzel, A., Mauler, J., Herzog, H. R., Boers, F., Mottaghy, F. M., Langen, K., Scheins, J. J., Lerche, C. W., Neumaier, B., Northoff, G., et al. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1027697
“, 2021) as well as with plasma GABA and [11C]flumazenil binding potential (Klumpers et al., 2010).”
BackgroundLewandrowski, K. U., Blum, K., Schmidt, S., Fiorelli, R. K. A., Gold, M. S., Mohankumar, K., Sharafshah, A., Bagchi, D., Pinhasov, A., Lorio, M. P., et al. (2026) · Substance Use & Misuse · doi:10.1080/10826084.2025.2612330
“…2011; Gabbay et al., 2012; Hasler et al., 2007; Price et al., 2009; Sanacora et al., 1999); decreased expression of GABA type A receptors (GABAARs) (Klumpers et al., 2010); lower expression of glutamic-acid decarboxylase (Guilloux et al., 2012; Karolewicz et al., 2010); and dysfunction of GABA…”
Blood-based biomarkers for traumatic brain injury
Rezzag, A. (2021) · theses.fr (ABES) · doi:10.70675/330bcff7z665fz4924z9a1bz947c6b1f9484
Sleeman, Z., Seferi, G., Khanal, P., Dalen, K. T., Morland, C., & Chaudhry, F. A. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.20.726495
Metadata
- Authors
- Klumpers, U. M. H., Veltman, D. J., Drent, M. L., Boellaard, R., Comans, E. F. I., Meynen, G., Lammertsma, A. A., & Hoogendijk, W. J. G.
- Affiliations
- Amsterdam UMC Location Vrije Universiteit Amsterdam (NL)
- Amsterdam Neuroscience (NL)
- Corresponding author
- Klumpers, Ursula M. H.
- ORCID
- Venue
- European Journal of Nuclear Medicine and Molecular Imaging
- Published
- 2009-11-05
- Volume
- 37
- Issue
- 3
- Pages
- 565-574
- ISSN
- 1619-7070 (ISSN-L)
- 1619-7089
- OpenAlex
- W2084145713
- Cited by
- 95
- References
- 66
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 2 · 2023: 6 · 2022: 3 · 2021: 9 · 2020: 3 · 2019: 9 · 2018: 5 · 2017: 9 · 2016: 7 · 2015: 3 · 2014: 5 · 2013: 8 · 2012: 9
- FWCI
- 4.33
- Type
- journal article
- Language
- en
- Open access
- green
- research.vumc.nl
- Licence
- other-oa
- www.springer.com/tdm (tdm)
- Locations
- European Journal of Nuclear Medicine and Molecular Imaging (publishedVersion)
- PubMed (publishedVersion)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion, other-oa)
- Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Pure Amsterdam UMC (submittedVersion, other-oa)
- VU Research Portal (submittedVersion, other-oa)
- Funders
- ZonMw
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- major depressive disorder, GABAA receptor, [11C]flumazenil, parahippocampal gyrus, HPA axis hyperactivity, citalopram, plasma GABA, insula, dorsolateral prefrontal cortex, temporal lobe, antidepressant response
- MeSH terms
- Adult, Antidepressive Agents, Carbon Radioisotopes, Corticotropin-Releasing Hormone, Major Depressive Disorder, Depressive Disorder, Major, Dexamethasone, Female, Flumazenil, gamma-Aminobutyric Acid, Humans, Male, Neurosecretory Systems, Protein Binding, Receptors, GABA-A, Case-Control Studies, Treatment Outcome, Parahippocampal Gyrus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.